<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-07-08T08:44:08Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/52268E7F-D55F-4041-9C2C-72A16D622090" ns1:id="52268E7F-D55F-4041-9C2C-72A16D622090"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/1518CDA0-172B-4ED3-8CAB-14C48476C199" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/B8BEE37C-D74E-4B18-B910-4077D2C490B6" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/AE4C4822-C567-49E4-85BE-343A2D0BD2A4" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/B8BEE37C-D74E-4B18-B910-4077D2C490B6" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/F2318DDA-009E-45F1-9CBE-3A8DB41D01FF" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/9CD67613-9501-482E-95B8-74B8FEBE7749" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/2C47D277-0550-454D-8F8D-C75FC6551D26" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2022-09-29T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/4A953408-2269-4D70-8F8A-F78859C3421B" ns1:rel="FUND" ns1:start="2019-03-01T00:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">104981</ns2:identifier></ns2:identifiers><ns2:title>Multifunctionalized Microalgae (MM) - A novel and flexible platform technology for maximising feed/energy conversion ratios and treating severe infections in livestock</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Collaborative R&amp;D</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>Production-purpose antibiotics are one of the great Faustian bargains of the modern era: mankind has traded

increased livestock yields today for AMR tomorrow. We propose that microalgae can be readily engineered to

express a wide range of naturally occurring antimicrobial and anti-inflammatory compounds which can both

substitute for production-purpose antibiotics as a means of maximizing feed/energy conversion ratios and treat

serious bacterial infections. Our objective in this project is to unequivocally demonstrate this using multi-

functionalized microalgae (MM) modified to accumulate two such agents in a series of rigorous field-trials in

both healthy and E.coli (K99)-infected calves. Our project is innovative in that MM can not only express these &amp;amp;

numerous other functional biochemical compounds, but also constitute a uniquely low-cost and practicable

platform technology. 350 million Chinese still live on less than $3/day and microalgae is the only combined

expression/delivery system capable of synthesizing the full range of bioactive agents required for managing the

complexity of intestinal flora which can be cultivated by both industrial-scale and LMIC artisanal farmers alike.</ns2:abstractText></ns2:project>